Late Intensification Therapy for Acute Leukemia in Remission
- 8 March 1976
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 235 (10), 1021-1025
- https://doi.org/10.1001/jama.1976.03260360023019
Abstract
Nineteen patients In continuous complete remission of acute leukemia for at least one year received late Intensification therapy, after which they received no further chemotherapy, but most received BCG Immunotherapy. Five patients have relapsed. The 14 patients still in remission have been followed up for at least 60 weeks after late intensification, with a median time of 98 weeks. The length of complete remission subsequent to a comparable time was 44 weeks for a reference control group and 24 weeks for a matched control group. These results support this type of approach for long-term control of acute leukemia in adults. (JAMA235:1021-1025, 1976)Keywords
This publication has 5 references indexed in Scilit:
- Studies of patients in a laminar air flow unitCancer, 1969
- Protected environment for cancer patients. Effect of a prophylactic antibiotic regimen on the microbial flora of patients undergoing cancer chemotherapyArchives of Internal Medicine, 1968
- A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored SamplesBiometrika, 1965
- Progress and Perspectives in the Chemotherapy of Acute LeukemiaPublished by Elsevier ,1965
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945